It is a postprandial insulin sensitizer, hence, improves glycaemic control in T2DM when glycemia is poorly controlled by metformin plus basal-bolus insulin, or individuals on high-dose basal-bolus insulin (91). This evidence concerns the gene INS and type 2 diabetes mellitus.